What question did this study set out to answer?

This study aims to investigate the role of GIPC2 in the progression of colorectal cancer and its underlying mechanisms.

June 14, 2026Gastroenterology reportOpen Access

GIPC2 suppresses colorectal cancer progression via regulation by UBA1-mediated ubiquitination

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial shows GIPC2 influences tumor progression in colorectal cancer, indicating potential therapeutic targets.

This study aims to investigate the role of GIPC2 in the progression of colorectal cancer and its underlying mechanisms.
Analyzed GIPC2 expression in CRC tissues and cell lines using TCGA data and western blotting.
Conducted functional assays including CCK-8, colony-formation, and transwell assays.
Performed in vivo GIPC2 knockdown and overexpression experiments to evaluate tumor growth effects.
GIPC2 expression was significantly lower in CRC samples, correlating with negative patient prognosis.
Functional assays demonstrated that GIPC2 inhibits CRC proliferation, migration, and invasion.
UBA1 interacts with GIPC2, leading to its ubiquitination and enhanced PI3K/AKT signaling pathway activation.

Cui et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark